SEC Comment Letter 0000000000-24-012630 to CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Date: Nov. 14, 2024 · CIK: 0001187953 · Accession: 0000000000-24-012630
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-283091
Letter
November 14, 2024 Timothy Warbington Chief Executive Officer Creative Medical Technology Holdings, Inc. 211 E Osborn Road Phoenix, Arizona 85012 Re:Creative Medical Technology Holdings, Inc. Registration Statement on Form S-1 Filed November 8, 2024 File No. 333-283091 Dear Timothy Warbington: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Zev M. Bomrind, Esq.
Show Raw Text
November 14, 2024
Timothy Warbington
Chief Executive Officer
Creative Medical Technology Holdings, Inc.
211 E Osborn Road
Phoenix, Arizona 85012
Re:Creative Medical Technology Holdings, Inc.
Registration Statement on Form S-1
Filed November 8, 2024
File No. 333-283091
Dear Timothy Warbington:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Zev M. Bomrind, Esq.